Literature DB >> 2839707

Multiple domains in the polyomavirus B enhancer are required for productive infection of F9 embryonal carcinoma cells.

R W Tseng1, F K Fujimura.   

Abstract

A point mutation at nucleotide 5258 in the B enhancer of the polyomavirus host range mutant F441 leads to productive infection of F9 embryonal carcinoma cells, which are refractory to infection by wild-type polyomavirus. Specific oligonucleotides were used to construct mutations in two other potentially important domains within the B enhancer of F441 DNA. One of these domains is the binding site for a factor present in nuclear extracts of F9 cells, and the other is a region that has sequence similarity to putative core sequences observed in a number of different viral enhancers. Mutation within either of these two domains, even in the presence of the F441 mutation, was detrimental to polyomavirus enhancer activity in F9 cells, as determined by both transfection and infection assays.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839707      PMCID: PMC253726          DOI: 10.1128/JVI.62.8.2890-2895.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Neoplastic differentiation: interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro.

Authors:  D E Swartzendruber; J M Lehman
Journal:  J Cell Physiol       Date:  1975-04       Impact factor: 6.384

2.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

3.  Polyoma virus infection of retinoic acid-induced differentiated teratocarcinoma cells.

Authors:  F K Fujimura; P E Silbert; W Eckhart; E Linney
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

4.  Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells.

Authors:  F K Fujimura; P L Deininger; T Friedmann; E Linney
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

5.  The nucleotide sequence and restriction enzyme sites of the polyoma genome.

Authors:  P L Deninger; A Esty; P LaPorte; H Hsu; T Friedmann
Journal:  Nucleic Acids Res       Date:  1980-02-25       Impact factor: 16.971

6.  Expression of polyoma early functions in mouse embryonal carcinoma cells depends on sequence rearrangements in the beginning of the late region.

Authors:  M Katinka; M Yaniv; M Vasseur; D Blangy
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

7.  A small segment of polyoma virus DNA enhances the expression of a cloned beta-globin gene over a distance of 1400 base pairs.

Authors:  J de Villiers; W Schaffner
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

8.  A trans-acting factor represses the activity of the polyoma virus enhancer in undifferentiated embryonal carcinoma cells.

Authors:  P Sassone-Corsi; C Fromental; P Chambon
Journal:  Oncogene Res       Date:  1987-07

9.  Isolation and characterization of polyoma host range mutants that replicate in nullipotential embryonal carcinoma cells.

Authors:  K Sekikawa; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

10.  Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells.

Authors:  M Katinka; M Vasseur; N Montreau; M Yaniv; D Blangy
Journal:  Nature       Date:  1981-04-23       Impact factor: 49.962

View more
  11 in total

1.  Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region.

Authors:  P Ostapchuk; G Scheirle; P Hearing
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

2.  Functional organization of the hepatitis B virus enhancer.

Authors:  R Dikstein; O Faktor; R Ben-Levy; Y Shaul
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

3.  Mutations of polyomavirus VP1 allow in vitro growth in undifferentiated cells and modify in vivo tissue replication specificity.

Authors:  B Mezes; P Amati
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

4.  Binding sites in mammalian genes and viral gene regulatory regions recognized by methylated DNA-binding protein.

Authors:  X Y Zhang; C K Asiedu; P C Supakar; R Khan; K C Ehrlich; M Ehrlich
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

5.  Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice.

Authors:  R Rochford; B A Campbell; L P Villarreal
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

6.  Mutations in the VP1 coding region of polyomavirus determine differentiating stage specificity.

Authors:  L Ricci; R Maione; C Passananti; A Felsani; P Amati
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  Aphidicolin-resistant polyomavirus and subgenomic cellular DNA synthesis occur early in the differentiation of cultured myoblasts to myotubes.

Authors:  N J DePolo; L P Villarreal
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins.

Authors:  W Reith; C Ucla; E Barras; A Gaud; B Durand; C Herrero-Sanchez; M Kobr; B Mach
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

9.  Unique requirement for the PyF441 mutation for polyomavirus infection of F9 embryonal carcinoma cells.

Authors:  R W Tseng; T Williams; F K Fujimura
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Protein recognition sites in polyomavirus enhancer: formation of a novel site for NF-1 factor in an enhancer mutant and characterization of a site in the enhancer D domain.

Authors:  M Caruso; C Iacobini; C Passananti; A Felsani; P Amati
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.